FDA Says Philips To Correct Affected OLA+ Ventilator With Software Patch To Address Ventilation Inoperative Alarm Issue
Portfolio Pulse from Benzinga Newsdesk
The FDA has announced that Philips will correct an issue with its OLA+ ventilator through a software patch. The patch addresses a problem with the ventilation inoperative alarm.
June 28, 2024 | 6:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Philips will release a software patch to correct an issue with the OLA+ ventilator's ventilation inoperative alarm, as announced by the FDA.
The news indicates a regulatory compliance action by Philips to address a specific issue with its OLA+ ventilator. While this is a necessary step to ensure product reliability and safety, it is not expected to have a significant short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100